The purpose of this study is to prospectively determine the diagnostic value of Xenetix-CT
perfusion for the discrimination between well-differentiated hepatocellular carcinomas (HCC)
and poorly/moderately differentiated HCC, in histo-pathologically proven HCC, and with the
aim to cover the entire liver.